Back to Search
Start Over
Supplementary Tables 1-3, Figures 1-4 from SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Tables 1-3, Figures 1-4 from SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....b253da2b8af69b57f61a86d3221a13f9
- Full Text :
- https://doi.org/10.1158/1535-7163.22485138